$NSIT: Insight Enterprises’ (NSIT) CEO Ken Lamneck on Q3 2018 Results …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Seeking Alpha (https://seekingalpha.com)

Summary: Insight Enterprises, Inc. (NASDAQ:NSIT) Q3 2018 Results Earnings Conference Call November 7, 2018 9:00 AM ET. Executives. Glynis Bryan …

Full article address: https://seekingalpha.com/article/4220768-insight-enterprises-nsit-ceo-ken-lamneck-q3-2018-results-earnings-call-transcript

Related News:

$NSIT: Insight Named NVIDIA Advanced Technology Partner

$NSIT: Insight Extends OneCall Support and Managed Services to …

$NSIT: Insight Celebrates Clients That Are Evolving Through Digital …

$NSIT: Insight Publishes First Corporate Citizenship Report

$NSIT: Insight Enterprises, Inc. (NSIT) CEO Kenneth Lamneck on Q4 2018 …

$NSIT: Insight Enterprises Inc (NSIT) Q4 2018 Earnings Conference Call …

$NSIT: Tempe company named one of Fortune’s best tech workplaces

$NSIT: Insight Ranks #23 on Fortune’s ‘Best Workplaces in Technology’

$NSIT: Insight Enterprises to Present at Investor Conference

$GCP $NSIT $LPI: Is GCP Applied Technologies Inc. (GCP) A Good Stock To Buy?

$NSIT $LPI: Here is What Hedge Funds Think About Insight Enterprises, Inc. (NSIT)

Latest News:

$BAC: Bank of America’s tech chief is skeptical on blockchain despite having the most patents for it

$YMM9 $ESM9 $NQM9 $SPX $COMP $DJIA: Market Snapshot: Dow futures climb as China trade talks set to resume

$MCD $NKE $RHT: Stocks to Watch: McDonald’s, Canopy Growth, Nike

$C: Citigroup Enters Banking’s Hottest Business With New Payments Unit

$DKS $GOOGL $HD $WMT: Dick’s Tech Chief Goes All Out on In-House Software

$SFTBY $MER-K $BCS $C $DB $MS: Uber Steers $3.1 Billion Careem Deal as Implied Value Gains Ahead of Planned IPO

$TTWO $NTDOY $ATVI $SNE $UBSFY $CCOEY: The Most Popular Video Games in the U.S.

$MKC: McCormick Beats Profit Estimates but Misses Slightly on Sales

$GES: Bear of the Day: Guess (GES)

$MCD $DPZ $CMG $YUM: McDonald’s Buys Dynamic Yield, Boosts Technology Offerings

$ASRT: Will Assertio Therapeutics Continue to Surge Higher?